secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2022-02-24T23:59:59+00:00
Accession:  0001493152-22-005399
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed appoints Shaun O'Neil as COO; $325K salary, 300K share option
--------------------------------------------------------------------

- Shaun O'Neil appointed COO effective Feb 22, 2022; previously Chief Commercial Officer since 2018.
- Employment agreement: $325,000 base salary, annual performance bonus up to 50% of base.
- Granted option to purchase 300,000 shares at $1.48 exercise price, vesting quarterly over 3 years.
- Initial term through Feb 2025, auto-renew; severance of 12 months base if terminated without cause.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315222005399/0001493152-22-005399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315222005399/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-005399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer